1 Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential dru..
来源:J NANOPART RES( P 1388-0764 E 1572-896X ) 发表时间: 2008/05
类型:期刊论文 为本人加分:24282.108852
2 Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitax..
来源:BIOMATERIALS( P 0142-9612 E 1878-5905 ) 发表时间: 2011/12
类型:期刊论文 为本人加分:11697.969687
贡献度:共同通讯作者
3 Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions
来源:INT J PHARMACEUT( P 0378-5173 E 1873-3476 ) 发表时间: 2008/05
类型:期刊论文 为本人加分:9635.000179
贡献度:单独通讯作者
4 Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical ..
来源:DRUG DEV IND PHARM( P 0363-9045 E 1520-5762 ) 发表时间: 2007/01
类型:期刊论文 为本人加分:8828.451990
5 Preparation and characterizations of a novel deoxycholic acid-O-carboxymethylated chitosan-folic aci..
来源:CARBOHYD POLYM( P 0144-8617 E 1879-1344 ) 发表时间: 2011/03
类型:期刊论文 为本人加分:7967.537482
贡献度:单独通讯作者
6 Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokineti..
来源:COLLOID SURFACE B( P 0927-7765 E 1873-4367 ) 发表时间: 2010/10
类型:期刊论文 为本人加分:7957.984814
贡献度:单独通讯作者
7 Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo
来源:INT J BIOL MACROMOL( P 0141-8130 E 1879-0003 ) 发表时间: 2007/01
类型:期刊论文 为本人加分:7597.488033
8 Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation m..
来源:EUR J PHARM SCI( P 0928-0987 E 1879-0720 ) 发表时间: 2012/09
类型:期刊论文 为本人加分:7160.455633
9 Galactose-Decorated pH-Responsive Nanogels for Hepatoma-Targeted Delivery of Oridonin
来源:BIOMACROMOLECULES( P 1525-7797 E 1526-4602 ) 发表时间: 2011/12
类型:期刊论文 为本人加分:6586.184142
贡献度:单独通讯作者
10 Stability of nanosuspensions in drug delivery
来源:J CONTROL RELEASE( P 0168-3659 E 1873-4995 ) 发表时间: 2013/12
类型:期刊论文 为本人加分:5941.389275